The addition of anthracyclines to adjuvant taxane-based chemotherapy improved survival for certain high-risk patients with ...

HER2-overexpressing breast cancer Trastuzumab, in combination with an anthracycline- and taxane-containing chemotherapy regimen, has become the universally-accepted standard of care for high-risk ...

Trials should examine the roles of these markers in the context of modern standard chemotherapy regimens including anthracyclines, as well as trastuzumab in HER2-overexpressing patients.

The global market for oncology drugs was valued at US$231.56 billion last year and is projected to soar to US$532.91 billion by 2031, according to Coherent (NYSE: COHR) Market Insights.

Heart failure resulting from treatments for non-cardiac medical conditions presents a significant challenge in clinical ...

The (AGA) has unveiled an updated clinical practice guideline in Gastroenterology addressing the prevention and management of hepatitis B virus reactivation (HBVr) in patients on immunosuppressive ...

Chemotherapy is a treatment used to kill ... into specific classes such as alkylating agents, antimetabolites, anthracyclines and topoisomerase inhibitors.

SON-1010, after receipt of data suggesting clinical benefit when administered as a monotherapy in patients with advanced solid tumors, enters ...